
EKNL does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for EKNL and 80,000+ other tickers.
See exactly how EKNL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for EKNL and 80,000+ other tickers.
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc. This partnership is responsible for the marketing and supply of frequency rhythmic electrical modulation system (FREMS) equipment throughout Canada, used in addressing peripheral neuropathy. Moreover, through the same joint venture, the company is involved in establishing and managing clinical facilities that provide patient care utilizing FREMS technology.
No recent news available.